Dureshahwar khan

adr pharmacovigilance pharmacoeconomics pharmaceutical care outcomes research role & responsibilities of pv cdsco pv program in india pv in industry case report form pv in hospitals pv pv works webvdme pharmacovigilance repclinical pvnet clintrace oracle aers arisg oracle argus safety softwares in pharmacovigilance adverse events tools in pharmacovigilance pharmacovigalance adr reporting form reporting process adr reporting aefi vaccine pharmacovigilance cross sectional study case control study cohort studies inn who-fic observational studies active surveillance passive surveillance icd ich e2d guidelines cioms meddra who art umc upsala monitoring centre who pidm medication safety vigibase who in pharmacovigilance who safety monitoring history of pharmacovigilance pvpi perspectives of pharmacoeconomics pharmacoeconomics evaluation development programs value added development program traditional development program advantages and disadvantages preclinical studies phases of clinical trials clinical trials healthcare ecosystem e records electronic medical records healthcare new paradigms humanistic outcome clinical outcome economic outcome echo three dimensional analysis cost-benefit analysis (cba) cost-utility analysis (cua) cost-effectiveness analysis (cea) economic analysis marginal benefit cost utility equity effeciency concepts in health economics health care health economics